Review
Aug 2026
Can agentic AI dent Eroom's Law? Large reasoning models across the drug discovery and development pipeline.
This review discusses agentic AI applications across the drug development continuum, from target discovery to post-market surveillance, and highlights three near-term use cases: algorithmic drug repurposing, informed consent support and automated drafting of regulatory documents.
Sheraz Khan, John G. Samuelsson, Xue-Mei Cai et al.
· Drug Discovery Today · 0 citations